☰

Ryan J. Ice, Ph.D. - Publications

Affiliations: 
2014 School of Medicine West Virginia University, Morgantown, WV, United States 
Area:
Oncology, Biochemistry, Pharmacology
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Purazo ML, Ice RJ, Shimpi R, Hoenerhoff M, Pugacheva EN. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers. 15. PMID 36831460 DOI: 10.3390/cancers15041119  0.755
2023 Sidorov M, Dighe P, Woo RWL, Rodriguez-Brotons A, Chen M, Ice RJ, Vaquero E, Jian D, Desprez PY, Nosrati M, Galvez L, Leng L, Dickinson L, Kashani-Sabet M, McAllister SD, et al. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells. 12. PMID 36831214 DOI: 10.3390/cells12040547  0.336
2022 Chen M, Jian D, Sidorov M, Woo RWL, Kim A, Stone DE, Nazarian A, Nosrati M, Ice RJ, de Semir D, Dar AA, Luštrik R, Kokošar J, Ausec L, Rowbotham MC, et al. Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience. Journal of Personalized Medicine. 12. PMID 36579573 DOI: 10.3390/jpm12111845  0.336
2020 Saqub H, Proetsch-Gugerbauer H, Bezrookove V, Nosrati M, Vaquero EM, de Semir D, Ice RJ, McAllister S, Soroceanu L, Kashani-Sabet M, Osorio R, Dar AA. Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9. Scientific Reports. 10: 18489. PMID 33116269 DOI: 10.1038/s41598-020-75578-5  0.4
2017 Pugacheva EN, Kozyreva V, Kiseleva A, Ice R, Jones B, Loskutov Y. Abstract 1084: Combination of eribulin and AURKA inhibitor prevents metastatic colonization and eradicates established metastases in breast cancer Cancer Research. 77: 1084-1084. DOI: 10.1158/1538-7445.Am2017-1084  0.733
2016 Kozyreva VK, Kiseleva A, Ice RJ, Jones BC, Loskutov YV, Matalkah F, Smolkin MB, Marinak K, Livengood RH, Salkeni MA, Wen S, Hazard HW, Layne GP, Walsh CM, Cantrell P, et al. Combination of Eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer. Molecular Cancer Therapeutics. PMID 27235164 DOI: 10.1158/1535-7163.Mct-15-0688  0.766
2016 Ice R, Kiseleva A, Loskutov Y, Smolkin M, Salkeni A, Hazard H, Layne G, Pugacheva E. Abstract B20: Development of metastatic patient-derived xenografts (PDXs) for accurate assessment of anti-metastatic therapeutics in pre-clinical settings Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B20  0.717
2015 Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, et al. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget. PMID 26079538 DOI: 10.18632/Oncotarget.4136  0.745
2015 Lin CC, Sharma SB, Farrugia MK, McLaughlin SL, Ice RJ, Loskutov YV, Pugacheva EN, Brundage KM, Chen D, Ruppert JM. Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. Oncogenesis. 4: e155. PMID 26053033 DOI: 10.1038/oncsis.2015.8  0.65
2015 Kozyulina PY, Loskutov YV, Kozyreva VK, Rajulapati A, Ice RJ, Jones BC, Pugacheva EN. Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins. Molecular Cancer Research : McR. 13: 423-38. PMID 25319010 DOI: 10.1158/1541-7786.Mcr-14-0353  0.673
2015 Loskutov YV, Kozyulina PY, Kozyreva VK, Ice RJ, Jones BC, Roston TJ, Smolkin MB, Ivanov AV, Wysolmerski RB, Pugacheva EN. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer. Oncogene. 34: 3662-75. PMID 25241893 DOI: 10.1038/Onc.2014.297  0.756
2014 Kozyreva VK, McLaughlin SL, Livengood RH, Calkins RA, Kelley LC, Rajulapati A, Ice RJ, Smolkin MB, Weed SA, Pugacheva EN. NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner. Molecular Cancer Research : McR. 12: 681-93. PMID 24574519 DOI: 10.1158/1541-7786.Mcr-13-0654  0.745
2014 McLaughlin SL, Ice RJ, Rajulapati A, Kozyulina PY, Livengood RH, Kozyreva VK, Loskutov YV, Culp MV, Weed SA, Ivanov AV, Pugacheva EN. NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis. Molecular Cancer Research : McR. 12: 69-81. PMID 24202705 DOI: 10.1158/1541-7786.Mcr-13-0300  0.775
2014 Pugacheva EN, McLaughlin S, Ice R, Rajulapati A, Kozyulina P, Livengood R, Kozyreva V, Loskutov Y, Ivanov A, Weed S. Abstract 2013: NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis Cancer Research. 74: 2013-2013. DOI: 10.1158/1538-7445.Am2014-2013  0.763
2013 Ice RJ, McLaughlin SL, Livengood RH, Culp MV, Eddy ER, Ivanov AV, Pugacheva EN. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors. Cancer Research. 73: 3168-80. PMID 23539442 DOI: 10.1158/0008-5472.Can-12-4008  0.741
2013 Ice RJ, Mahavadi SA, Pugacheva EN. Abstract A094: The influence of pro-metastatic protein NEDD9 expression in supporting distant breast cancer metastasis Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A094  0.786
2013 Pugacheva EN, Loskutov Y, McLaughlin S, Kozyulina P, Kozyreva V, Ice R, Culp M, Wysolmerski R, Weed S, Ivanov A. Abstract A66: NEDD9 promotes cell invasion through modulation of ARF6 activity and endocytic recycling Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A66  0.764
2013 Loskutov Y, McLaughlin S, Kozyulina P, Kozyreva V, Ice R, Rajulapati A, Culp M, Wysolmerski R, Ivanov A, Weed S, Pugacheva E. Abstract 3782: NEDD9 promotes cell invasion through modulation of Arf6-dependent endocytic recycling. Cancer Research. 73: 3782-3782. DOI: 10.1158/1538-7445.Am2013-3782  0.786
2013 Ice RJ, McLaughlin S, Culp M, Eddy E, Livengood R, Pugacheva E. Abstract 3384: Depletion of NEDD9 destabilizes Aurora A kinase and augments efficacy of inhibitors. Cancer Research. 73: 3384-3384. DOI: 10.1158/1538-7445.Am2013-3384  0.737
Show low-probability matches.